MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Clinical trials for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) explained in plain language.
Never miss a new study
Get alerted when new MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) trials appear
Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug trial aims to stop blood cancer before it starts
Prevention Recruiting nowThis study is testing an investigational drug called linvoseltamab in people who have early, precancerous blood conditions that put them at moderate risk of developing multiple myeloma. The main goal is to see if the drug can eliminate the abnormal cells and signs of these condit…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Prevention
Last updated Apr 01, 2026 14:42 UTC
-
Major charlotte study hunts for early blood cancer signs before It's too late
Knowledge-focused Recruiting nowThis study aims to find early signs of multiple myeloma, a type of blood cancer, in people before they develop symptoms. Researchers will screen over 1,600 adults in the Charlotte area who are at higher risk, primarily focusing on Black/African American individuals and relatives …
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Massive 10,000-Person study seeks clues to stop blood cancer before it starts
Knowledge-focused Recruiting nowThis study aims to understand why some early, non-symptomatic blood conditions turn into cancer. Researchers will observe 10,000 adults who have these early conditions or a history of cancer. They will analyze genetic material from routine blood and tissue samples to identify cha…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC